Anti‐atherogenic and anti‐inflammatory properties of glucagon‐like peptide‐1, glucose‐dependent insulinotropic polypepide, and dipeptidyl peptidase‐4 inhibitors in experimental animals

We reported that native incretins, liraglutide and dipeptidyl peptidase‐4 inhibitors (DPP‐4i) all confer an anti‐atherosclerotic effect in apolipoprotein E‐null (Apoe (−/−)) mice. We confirmed the anti‐atherogenic property of incretin‐related agents in the mouse wire injury model, in which the neoin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirano, Tsutomu, Mori, Yusaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Proceedings of INCRETIN 2015, A Symposium Celebrating the 45th Anniversary of the Discovery of GIP, 29–31 July 2015, Vancouver, Canada. This publication has been supported by: The Local Organizing Committee of INCRETIN 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854510/
https://www.ncbi.nlm.nih.gov/pubmed/27186361
http://dx.doi.org/10.1111/jdi.12446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854510/
https://www.ncbi.nlm.nih.gov/pubmed/27186361
http://dx.doi.org/10.1111/jdi.12446

Ejemplares similares